NDAORALTABLET, EXTENDED RELEASE
Approved
Apr 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
KLOR-CON (potassium chloride) by Ascentage Pharma is tissues. First approved in 1986.
Drug data last refreshed 12h ago · AI intelligence enriched 14h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
KLOR-CON is an oral extended-release tablet formulation of potassium chloride, a vital electrolyte that maintains cellular function, nerve transmission, and cardiac/skeletal muscle contraction. It is used to treat or prevent hypokalemia (low potassium levels) in patients with potassium depletion due to disease or medication. Potassium works by restoring intracellular and plasma potassium concentrations to normal physiological levels (3.5–5 mEq/L).
$11MPart D
LOE ApproachingStable
This legacy product is approaching loss of exclusivity with minimal recent spending and limited job-creation potential; teams are likely focused on cost management rather than growth.
Mechanism of Action
tissues. Potassium ions participate in a number of essential physiological processes including the maintenance of intracellular tonicity, the transmission of nerve impulses, the contraction of cardiac, skeletal and smooth muscle and the maintenance of normal renal function. The intracellular…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on KLOR-CON offers limited career growth or visibility; the product is in late-stage lifecycle with minimal hiring and focus on margin protection rather than innovation. This role suits professionals seeking stable, low-intensity work or those transitioning from higher-growth portfolios.
Brand Manager
Worked on KLOR-CON at Ascentage Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.